Biotechnology Bulletin ›› 2018, Vol. 34 ›› Issue (12): 32-40.doi: 10.13560/j.cnki.biotech.bull.1985.2018-0504
• Orginal Article • Previous Articles Next Articles
WANG Zhao-yang1, LAN Li-ming1, BAI Ding-ping1, ZHANG Fu-jun2, LI Ang1
Received:
2018-05-28
Online:
2018-12-26
Published:
2018-12-24
WANG Zhao-yang, LAN Li-ming, BAI Ding-ping, ZHANG Fu-jun, LI Ang. Research Advance on PPARα Gene in Livestock and Poultry[J]. Biotechnology Bulletin, 2018, 34(12): 32-40.
[1] Grygiel-Górniak B.Peroxisome proliferator-activated receptors and their ligands:nutritional and clinical implications-a review[J]. Nutrition Journal, 2014, 13(1):17. [2] Issemann I, Green S.Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators[J]. Nature, 1990, 347(6294):645-650. [3] Bookout AL, Jeong Y, Downes M, et al.Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network[J]. Cell, 2006, 126(4):789-799. [4] Wahli W, Michalik L.PPARs at the crossroads of lipid signaling and inflammation[J]. Trends in Endocrinology & Metabolism Tem, 2012, 23(7):351-363. [5] Sasaki T, Nakata R, Inoue H, et al.Role of AMPK and PPARγ1 in exercise-induced lipoprotein lipase in skeletal muscle[J]. American Journal of Physiology Endocrinology & Metabolism, 2014, 306(9):E1085-E1092. [6] Lamichane S, Dahal BL, Kwon SM. Pivotal roles of peroxisome proliferator-activated receptors(PPARs)and their signal cascade for cellular and whole-body energy homeostasis[J]. International Journal of Molecular Sciences, 2018, 19(4). pii:E949. [7] Rajamani K, Colman PG, Li LP, et al.Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus(FIELD study):a prespecified analysis of a randomised controlled trial[J]. Lancet, 2009, 373(9677):1780-1788. [8] 马云, 王云云, 张晓婷, 等. 鸭PPARα基因结构及功能的生物信息学分析[J]. 浙江大学学报:农业与生命科学版, 2011, 37(4):371-379. [9] 饶辽源, 周靖宣, 王林杰, 等. 山羊PPARα基因克隆、分子特性及组织差异表达分析[J]. 中国畜牧兽医, 2018, 45(3):559-570. [10] 冯秉仁, 徐凯, 李步高, 等. 猪PPARα蛋白的生物信息学分析[J]. 当代畜牧, 2014(29):93-96. [11] 林森, 徐亚欧, 林亚秋, 等. 藏鸡PPARα基因克隆与生物信息学分析[J]. 西南民族大学学报:自然科学版, 2015, 41(6):661-666. [12] Kersten S, Stienstra R.The role and regulation of the peroxisome proliferator activated receptor alpha in human liver[J]. Biochimie, 2017, 136:75-84. [13] Desvergne B, Wahli W.Peroxisome proliferator-activated receptors:nuclear control of metabolism[J]. Endocrine Reviews, 1999, 20(5):649-688. [14] Vohl MC, Lepage P, Gaudet D, et al.Molecular scanning of the human PPARα gene:association of the L162V mutation with hyperapobetalipoproteinemia[J]. Journal of Lipid Research, 2000, 41(6):945-952. [15] Pyper SR, Viswakarma N, Yu S, et al.PPARα:energy combustion, hypolipidemia, inflammation and cancer[J]. Nuclear Receptor Signaling, 2010, 8:e002. [16] Hummasti S, Tontonoz P.The peroxisome proliferator-activated receptor N-terminal domain controls isotype-selective gene expression and adipogenesis[J]. Molecular Endocrinology, 2006, 20(6):1261-1275. [17] Liu MH, Li J, Shen P, et al.A natural polymorphism in peroxisome proliferator-activated receptor-alpha hinge region attenuates transcription due to defective release of nuclear receptor corepressor from chromatin[J]. Molecular Endocrinology, 2008, 22(5):1078-1092. [18] Chandran K, Goswami S, Sharmawalia N.Implications of a peroxisome proliferator-activated receptor alpha(PPARα)ligand clofibrate in breast cancer[J]. Oncotarget, 2015, 7(13):15577-15599. [19] Kusu R, Oishi A, Kakizawa K, et al.Effects of phthalate ester derivatives including oxidized metabolites on coactivator recruiting by PPARalpha and PPARgamma[J]. Toxicology in Vitro, 2008, 22(6):1534-1538. [20] Kim T, Wahyudi LD, Gonzalez FJ, et al.Nuclear receptor PPARα agonist Wy-14, 643 ameliorates hepatic cell death in hepatic IKKβ-deficient mice[J]. Biomolecules & Therapeutics, 2017, 25(5):504-510. [21] Georgiadi A, Kersten S.Mechanisms of gene regulation by fatty acids[J]. Advances in Nutrition, 2012, 3(2):127-134. [22] Chakravarthy MV, Lodhi IJ, Yin L, et al.Identification of a physiologically relevant endogenous ligand for PPARalpha in liver[J]. Cell, 2009, 138(3):476-488. [23] Crisafulli C, Cuzzocrea S.The role of endogenous and exogenous ligands for the peroxisome proliferator-activated receptor alpha(PPAR-alpha)in the regulation of inflammation in macrophages[J]. Shock, 2009, 32(1):62-73. [24] Ng VY, HuangY, Reddy LM, et al. Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated eceptor α[J]. rug Metabolism & Disposition, 2007, 35(7):1126-1134. [25] Yan Y, Wang ZB, Tang CK.PPARs mediate the regulation of energy metabolism by long-chain fatty acids[J]. Progress in Physiological Sciences, 2016, 47(1):1-6. [26] Reddy JK, Hashimoto T.Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha:an adaptive metabolic system[J]. Annual Review of Nutrition, 2001, 21(21):193-230. [27] Fransen M, Nordgren M, Wang B, et al.Aging, age-related diseases and peroxisomes[M]// Peroxisomes and their Key Role in Cellular Signaling and Metabolism. Springer Netherlands, 2013:45-65. [28] Yeldandi AV, Rao MS, Reddy JK.Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis[J]. Mutation Research/fundamental & Molecular Mechanisms of Mutagenesis, 2000, 448(2):159-177. [29] Baes M, Van Veldhoven PP.Hepatic dysfunction in peroxisomal disorders[J]. Biochim Biophys Acta, 2016, 1863(5):956-970. [30] Jia Y, Qi C, Zhang Z, et al.Overexpression of peroxisome proliferator-activated receptor-alpha(PPARalpha)-regulated genes in liver in the absence of peroxisome proliferation in mice deficient in both L-and D-forms of enoyl-CoA hydratase/dehydrogenase enzymes of peroxisomal beta-oxi[J]. J Biol Chem, 2003, 278(47):47232-47239. [31] Martens K, Ver Lv TE, van Batenburg MF, et al. Coordinate induction of PPAR alpha and SREBP2 in multifunctional protein 2 deficient mice[J]. Biochimica Et Biophysica Acta Molecular & Cell Biology of Lipids, 2008, 1781(11-12):694-702. [32] Ip E, Farrell GC, Robertson G, et al.Central role of PPARα-dependent hepatic lipid turnover in dietary steatohepatitis in mice[J]. Hepatology, 2003, 38(1):123-132. [33] Rao MS, Reddy JK.Peroxisomal beta-oxidation and steatohepatitis[J]. Seminars in Liver Disease, 2001, 21(1):43-55. [34] Chakravarthy MV, Lodhi IJ, Yin L, et al.Identification of a physiologically relevant endogenous ligand for PPARalpha in liver[J]. Cell, 2009, 138(3):476-488. [35] Hines IN, Kremer M, Moore SM, et al.Impaired T cell-mediated hepatitis in peroxisome proliferator activated receptor alpha(PPARα)-deficient mice[J]. Biol Res, 2018, 51(1):5. [36] Yu S, Reddy JK.Transcription coactivators for peroxisome proliferator-activated receptors[J]. Biochimica et Biophysica Acta, 2007, 1771(8):936-951. [37] Montagner A, Polizzi A, Fouché E, et al.Original article:Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD[J]. Gut, 2016, 65(7):1202-1214. [38] Evans RM, Mangelsdorf DJ.Nuclear receptors, RXR, and the big bang.[J]. Cell, 2014, 157(1):255-266. [39] Meer DLMVD, Degenhardt T, Väisänen S, et al.Profiling of promoter occupancy by PPARα in human hepatoma cells via ChIP-chip analysis[J]. Nucleic Acids Research, 2010, 38(9):2839-2850. [40] Feige JN, Gelman L, Michalik L, et al.From molecular action to physiological outputs:peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions[J]. Progress in Lipid Research, 2006, 45(2):120-159. [41] Michalik L, Auwerx J, Berger JP, et al.International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors[J]. Pharmacological Reviews, 2006, 58(4):726-741. [42] Serviddio G, Bellanti F, Vendemiale G.Free radical biology for medicine:learning from nonalcoholic fatty liver disease[J]. Free Radical Biology & Medicine, 2013, 65(6):952-968. [43] Rui L.Energy metabolism in the liver[J]. Comprehensive Physiology, 2014, 4(1):177-197. [44] Evans RM, Barish GD, Wang YX.PPARs and the complex journey to obesity[J]. Nature Medicine, 2004, 10(4):355-361. [45] Misra P, Reddy JK.Peroxisome proliferator-activated receptor-α activation and excess energy burning in hepatocarcinogenesis[J]. Biochimie, 2014, 98(1):63-74. [46] Mei CL, He P, Cheng B, et al.Chlamydia pneumoniae induces macrophage-derived foam cell formation via PPAR alpha and PPAR gamma-dependent pathways[J]. Cell Biology International, 2009, 33(3):301-308. [47] de la Rosa Rodriguez MA, Kersten S. Regulation of lipid droplet-associated proteins by peroxisome proliferator-activated receptors[J]. Biochimica Et Biophysica Acta, 2017, 1862(10):1212-1220. [48] Linden AG, Li S, Choi HY, et al.Interplay between ChREBP and SREBP-1c coordinates postprandial glycolysis and lipogenesis in livers of mice[J]. Journal of Lipid Research, 2018, 59(3):475-487. [49] Hostetler HA, Huang H, Kier AB, et al.Glucose directly links to lipid metabolism through high affinity interaction with peroxisome proliferator-activated receptor alpha[J]. J Biol Chem, 2008, 283(4):2246-2254. [50] Wang YX, Lee CH, Tiep S, et al.Peroxisome-proliferator-activated receptor δ activates fat metabolism to prevent obesity[J]. Cell, 2003, 113(2):159-170. [51] Yu S, Matsusue K, Kashireddy P, et al.Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1(PPARgamma1)overexpression[J]. J Biol Chem, 2003, 278(1):498-505. [52] Balanarasimha M, Davis AM, Soman FL, et al.Ligand-regulated heterodimerization of peroxisome proliferator-activated receptor α with liver X receptor α[J]. Biochemistry, 2014, 53(16):2632-2643. [53] Baes M, Van Veldhoven PP.Hepatic dysfunction in peroxisomal disorders[J]. Biochim Biophys Acta, 2016, 1863(5):956-970. [54] Sanderson LM, Degenhardt T, Koppen A, et al.Peroxisome proliferator-activated receptor β/δ(PPARβ/δ)but not PPARα serves as a plasma free fatty acid sensor in liver[J]. Molecular & Cellular Biology, 2009, 29(23):6257-6267. [55] Nakamura MT, Yudell BE, Loor JJ.Regulation of energy metabolism by long-chain fatty acids[J]. Progress in Lipid Research, 2014, 53(1):124-144. [56] Ferdinandusse S, Denis S, Faust PL, et al.Bile acids:the role of peroxisomes[J]. Journal of Lipid Research, 2009, 50(11):2139-2147. [57] Rui LY.Energy metabolism in the liver[J]. Comprehensive Physiology, 2014, 4(1):177-197. [58] Bi L, Jiang Z, Zhou J.The role of lipin-1 in the pathogenesis of alcoholic fatty liver[J]. Alcohol & Alcoholism, 2015, 50(2):146. [59] Jia Y, Qi C, Zhang Z, et al.Overexpression of peroxisome proliferator-activated receptor-alpha(PPARalpha)-regulated genes in liver in the absence of peroxisome proliferation in mice deficient in both L-and D-forms of enoyl-CoA hydratase/dehydrogenase enzymes of peroxisomal beta-oxi[J]. J Biol Chem, 2003, 278(47):47232-47239. [60] Kliewer SA, Xu HE, Lambert MH, et al.Peroxisome proliferator-activated receptors:from genes to physiology[J]. Recent Prog Horm Res, 2001, 56(1):239-263. [61] Wolfrum C, Spener F.Fatty acids as regulators of lipid metabolism[J]. European Journal of Lipid Science & Technology, 2015, 102(12):746-762. [62] Reddy JK.Peroxisome proliferators and peroxisome proliferator-activated receptor alpha:biotic and xenobiotic sensing[J]. American Journal of Pathology, 2004, 164(6):2305-2321. [63] Antonenkov VD, Hiltunen JK.Transfer of metabolites across the peroxisomal membrane[J]. Biochimica Et Biophysica Acta, 2012, 1822(9):1374-1386. [64] 陈兴勇, 赵宁, 张燕, 等. 皖西白鹅育肥期肌肉脂肪酸组成及肝PPARα、FADS2和ME1基因表达规律的研究[J]. 畜牧兽医学报, 2017, 48(10):1912-1919. [65] 林婄婄, 高中元, 袁亚男, 等. PPARα和PPARγ基因在不同脂尾型绵羊脂肪组织中的发育性表达研究[J]. 畜牧兽医学报, 2012, 43(9):1369-1376. [66] Luo JB, Tian JY, Tao ZR, et al.Regulatory expression of peroxisome proliferatoractivated receptors genes during fatty liver formation in geese[J]. Journal of Integrative Agriculture, 2010, 9(1):113-120. [67] 贺綦, 史洪岩, 王海霞, 等. 鸡转录因子C/EBPα、KLF2、KLF3、KLF7、PPARα对L-FABP启动子活性的影响[J]. 中国畜牧杂志, 2014, 50(17):13-17. [68] 徐凯, 王效京, 刘宏, 等. 过氧化物酶体增殖物激活受体α在猪肝脏组织中发育性表达研究[J]. 中国畜牧兽医, 2014, 41(10):178-182. [69] 李彦莹, 周天予, 杨振, 等. 鸭PPARs启动子扩增、序列比较及其转录因子表达模式的聚类分析[J]. 农业生物技术学报, 2016, 24(12):1890-1899. [70] 武子寅, 温彦涛, 黎寿丰, 等. 鸡PPARα基因多态性与肉质性状关联的研究[J]. 中国家禽, 2013, 35(7):9-12. [71] 方文良, 黄金明, 王长法, 等. 中国荷斯坦牛PPARα基因多态性研究及其与耐热性能的关联分析[J]. 中国畜牧兽医, 2012, 39(8):165-170. [72] 李芬, 李荣荣, 张琼琼, 等. 中国地方黄牛PPARα exon7基因多态性与生长性状的关联研究[J]. 中国牛业科学, 2016, 42(1):1-5. [73] 田亚东, 亢娟娟, 孙桂荣, 等. PPARα基因对安卡×固始鸡资源群胴体品质的遗传效应分析[J]. 华北农学报, 2010, 25(6):14-18. |
[1] | JIANG Xian-zhe, ZHANG Bo-yan, LUO Hai-ling, ZHANG Xin-meng, WANG Bing. Role of Gut-Liver Axis in Animal Nutritional Metabolism and Immunity [J]. Biotechnology Bulletin, 2022, 38(7): 128-135. |
[2] | SUN De-quan, LU Xin-hua, LI Wei-ming, HU Yu-lin, DUAN Ya-jie, PANG Zhen-cai, HU Hui-gang. Application of Mesoporous Silica Nanoparticles in Agriculture [J]. Biotechnology Bulletin, 2022, 38(5): 228-239. |
[3] | YAN Jiong, FENG Chen-yi, GAO Xue-kun, XU Xiang, YANG Jia-min, CHEN Zhao-yang. Construction of Homozygous Plin1-knockout Mouse Model and Phenotype Analysis Based on CRISPR/Cas9 Technology [J]. Biotechnology Bulletin, 2022, 38(3): 173-180. |
[4] | ZHONG Ming-yue, LIU Chun-yan, YAN Yan, ZHANG Xiao-hui, YUAN Hai-sheng, XU Guo-quan, ZHANG He-ping, WANG Yu-zhen. Improvement Effect of Bifidobacterium lactis V9 on NAFLD Rats Induced by High-fat Diet [J]. Biotechnology Bulletin, 2022, 38(3): 181-187. |
[5] | ZHU Wen, TANG Ying-ying, SUN Xin-yang, ZHOU Ming, ZHANG Zi-jun, CHEN Xing-yong. Effect of Low Crude Protein Diet on the Liver Transcriptome Sequencing of Goats [J]. Biotechnology Bulletin, 2021, 37(9): 203-211. |
[6] | QIAO Zi-peng, WANG Qi-zhi, YANG Dao-mao, RUAN Li-ping. Research Progress in Fungi-mediated Biosynthesis of Sliver Nanoparticles [J]. Biotechnology Bulletin, 2021, 37(3): 185-197. |
[7] | ZHANG Hao, ZHANG Ya-nan, LI Xin, WANG Jia-mei, WANG Yong, ZHU Jiang-jiang, XIONG Yan, LIN Ya-qiu. Effect of PDK4 on the Lipid Metabolism of Goat Intramuscular Adipocytes [J]. Biotechnology Bulletin, 2021, 37(12): 151-159. |
[8] | LI Xue, LI Jun-min, ZHANG Lei, LI Shan. Expression and Purification of Cell-penetrating Peptide M918 Conjugate Antibody and Study on Its Uptake Efficiency [J]. Biotechnology Bulletin, 2021, 37(12): 198-204. |
[9] | GUO Dong-dong, SUN Fen, HE Xuan-ang, YANG Dong-ye, HUANG Lai-qiang. Application and Prospects of Single-Cell Sequencing in Liver Disease [J]. Biotechnology Bulletin, 2021, 37(1): 137-144. |
[10] | ZHAO Xu, XU Qun, HOU Yan-ru, LI Ming-yu, ZHANG Ya-ning, WANG Hai. Effects of ANGPTL4 on Intestinal Microbiota Affecting Lipid Metabolism of Animals [J]. Biotechnology Bulletin, 2020, 36(6): 230-235. |
[11] | CHANG Yun-jian, KANG Ran, XUE Xuan, WANG Shao-chang, ZHAO Qing-wen, GUO Zhi-yun. Identification and Functional Analysis of Enhancers-regulated miRNA Feed-forward Loops in Hepatocellular Carcinoma [J]. Biotechnology Bulletin, 2019, 35(5): 140-145. |
[12] | MING Peng-fei, HUANG Ying-ying, DONG Yan-li, NIE Xing-can, FENG Shi-bin, WANG Xi-chun, CHENG Jian-bo, LI Jin-chun, WU Jin-jie, LI Yu. Regulation of LKB1-AMPKα-SIRT1 Signal Pathway in Lipid Metabolism in the Adipose Tissue of Dairy Cows [J]. Biotechnology Bulletin, 2019, 35(2): 176-181. |
[13] | YAO Lin-tong, LIU Ya-ting, LIU Ya-jing, CHEN Zhen-zhen. Research Progress on Mesoporous Silica in Cancer Therapy [J]. Biotechnology Bulletin, 2019, 35(2): 182-191. |
[14] | ZHANG Wen-jun, WU Meng-ting, LÜ Chun-yan, WANG Qing, CHEN Yong-lin. Research Progress on Mesoporous Silica in Drug Delivery System and in vitro/in vivo [J]. Biotechnology Bulletin, 2019, 35(12): 159-168. |
[15] | ZHANG Yang-zi, ZHU Long-jiao, SHAO Xiang-Li, XU Wen-tao. Research Progress on Biosensing and Drug Delivery Mediated by the Staudinger Ligation [J]. Biotechnology Bulletin, 2019, 35(1): 187-198. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||